Clonidine Stimulation Test: Is Single Best Time Point, Convenient Yet Efficacious?

Area of Science:

• Pediatric Endocrinology
• Diagnostic Testing
• Growth Hormone Disorders

Background:

• Growth hormone deficiency (GHD) is a significant cause of short stature in children.
• Accurate diagnosis of GHD is crucial for timely intervention and treatment.
• The clonidine stimulation test (CST) is commonly used to assess growth hormone (GH) secretion.

Purpose of the Study:

• To identify the optimal single time point during the CST for diagnosing growth hormone deficiency (GHD).
• To evaluate the diagnostic value of single and combined time points in the CST.
• To determine the most effective strategy for ruling out GHD in children with short stature.

Main Methods:

• Retrospective analysis of 79 clonidine stimulation tests (CSTs) in children with unexplained short stature.
• Children were categorized into GHD and non-GHD groups.
• Diagnostic accuracy, specificity, and false positive rates were calculated for single and paired time points.

Main Results:

• A single sample at 60 minutes post-clonidine showed a specificity of 79.5% with 20.5% false positives.
• Adding the 90-minute sample significantly increased specificity to 92.3%.
• The 60-minute time point demonstrated the highest diagnostic value as a single sample.

Conclusions:

• The 60-minute sample after clonidine administration is the most effective single time point for ruling out GHD.
• Combining 60-minute and 90-minute samples offers an economical and less cumbersome approach with minimal loss of specificity.
• This study provides evidence for optimizing CST protocols in diagnosing GHD.